Read the Research

Two companies, on two continents, are racing to bring a topical androgen receptor antagonist to market for pattern hair loss: Cosmo Pharmaceuticals with clas...

KX-826, also known as pyrilutamide, is a topical androgen receptor antagonist developed by Kintor Pharmaceutical, a publicly listed Chinese biotech. It's the...

KX-826, also known as pyrilutamide, is a topical androgen receptor antagonist developed by Kintor Pharmaceutical (HKEX: 9939), a publicly listed biotech base...

RU58841 is a topical androgen receptor antagonist, an unapproved compound sold through research-chemical suppliers and used off-label by parts of the hair lo...

Search around for VDPHL01 and you'll find fluid retention mentioned constantly, usually as a reason people avoid oral minoxidil altogether, and usually impli...

Our earlier article on oral minoxidil covered the current shift toward oral prescribing, and made a point of noting that the tablets being prescribed are imm...

The two main pharmacological approaches to androgenetic hair loss work in very different ways: minoxidil affects the growth cycle without directly targeting ...

Something has genuinely changed in how minoxidil gets prescribed. For nearly four decades it meant a solution or foam applied twice daily to the scalp. Over ...

"Ozempic face" isn't a medical diagnosis and it isn't a labelled side effect of any GLP-1 drug. It's a media term for a real, dermatologist-observed pattern:...

Ketoconazole shampoo is licensed primarily for dandruff and seborrhoeic dermatitis, a scalp condition linked to an overgrowth of the yeast Malassezia. It's a...